Description
A non-selective COX inhibitor (IC50s = 0.5 and 2.33 µM for human COX-1 and COX-2, respectively); reduces carrageenan-induced paw edema and increases latency to paw withdrawal in the hot plate test in rats when administered using a sustained-release implant,
Formal name: 3-benzoyl-α-methyl-benzeneacetic acid
Synonyms: (R,S)-Ketoprofen|2-(3-benzoylphenyl)Propionic Acid
Molecular weight: 254.3
CAS: 22071-15-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway